At Snipr Biome, preparations to break out of its mold have begun.
Even though the company's main focus has been developing treatments for difficult-to-treat infections, Snipr is now setting its sights on an entirely new area by partnering with the prestigious Texan cancer hospital MD Anderson. Snipr is now going to help the improve side effects of immune therapy.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Stallergenes Greer enters partnership to develop device and app
Stallergenes Greer and Aptar Pharma will collaborate to develop a new connected device with a companion app for patients going through treatment with the allergy company's allergen immunotherapy.
Lundbeck chairman demands change: "We can't live with this"
Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.
Coloplast could win big on Polish reimbursement changes
The Polish Ministry of Health has increased the reimbursement amount for hydrophilic catheters, which Coloplast supplies. The Danish medtech company calls the new scheme a "breakthrough."
Several positive elements in Eli Lilly Q3 report, says analyst
.jpg)
An analyst at Sydbank thinks that Eli Lilly's third quarter report includes a number of positive elements, and emphasizes that this could also be good news for competitor Novo Nordisk.
Eli Lilly upgrades earnings per share guidance
On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.
Software Developer, Cardiac Applications – Medical Devices, DK 
Medical Director 
Regulatory Science Specialist 
Principal Statistician / Statistical Project Director 
Senior Legal Advisor 
Senior Manager Pharmaceutical Development and Manufacturing 
Senior Training and Learning Expert – Help us build a best-in-class global learning and quality culture 
Senior Clinical Trial Manager 
Head of Engineering, Syntese 
Associate Director – MedTech Manufacturing 
VP, Head of CMC Pharmaceutical and Device Development 
KLIFO is looking for a talented and committed Pharmacovigilance Associate based in Denmark 
Clinical Documentation Specialist 
QA Specialist wanted 
Nordic Field Sales Manager